Pharmaceutical Drugs Global Market Report 2018

1. Pharmaceutical Drugs Global Market Report 2018 Including: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs Covering: Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences Inc. Feb 2018

2. Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Scope Markets Covered: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs. Companies Mentioned: Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences Inc. Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Pharmaceutical Drugs Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

3. Pharmaceutical Drugs Pharmaceutical Drugs Market Characteristics Characteristics Market The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients. Pharmaceutical preparations are drugs intended for human or veterinary use presented in their finished dosage form. Companies engaged in pharmaceutical preparations are involved in drug discovery and development, manufacturing, drug processing and sales and marketing of drugs for human or veterinary use. Tablets, ampoules, capsules, ointments and medicinal powders and solutions are the various pharmaceutical preparations produced by pharmaceutical companies. The pharmaceutical drugs market is segmented as follows: Musculoskeletal Disorders Drugs market comprises companies that Cardiovascular Drugs market covers the drugs used to treat conditions that affect the heart or Oncology Drugs prevent the growth of malignant tumors by affecting the process of cell division or by Anti-infective Drugs are used to treat infectious diseases caused by several pathogenic organisms such as Metabolic Disorder Drugs market covers medications that are used in the

4. Central Nervous System Drugs market includes drugs that are used for the treatment of a Genito-urinary Drugs market covers drugs that are used in the treatment of diseases such as Respiratory Drugs market covers drugs that are used in the treatment of a wide range of Gastrointestinal Drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, and Hematology Drugs market offers drugs, blood and blood products that are used for the Dermatology Drugs market includes medications that are used for the treatment of skin conditions such as Ophthalmology Drugs market covers drugs that are used in In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.

5. Pharmaceutical Drugs Pharmaceutical Drugs Market Historic Growth Historic Growth Market The global pharmaceutical drugs market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global pharmaceutical drugs market during 2013 – 2017. Drivers of the Market: Restraints on the Market:

6. Pharmaceutical Drugs Pharmaceutical Drugs Market Forecast Growth Forecast Growth Market The global pharmaceutical drugs market is expected to grow from $XX billion in 2017 to $1,170 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global pharmaceutical drugs market during 2017 - 2021. Drivers of the Market: Restraints on the Market:

7. Pharmaceutical Drugs Pharmaceutical Drugs Market Segmentation Segmentation Market The chart and table below shows the split of the pharmaceutical drugs market in 2017.

8. The total market value for pharmaceutical drugs was $X billion in 2017. The markets that are covered include Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs. Musculoskeletal Disorders Drugs was the X largest segment in the pharmaceutical drugs market with X% share of the market. The market value for the musculoskeletal disorders drugs was $X billion in 2017. Cardiovascular Drugs made up around X% share of the market. The market value for the cardiovascular drugs was $X billion in 2017.

9. Pharmaceutical Drugs Pharmaceutical Drugs Market Regional And Country Analysis Regional And Country Analysis Market The Asia Pacific was the largest region in the pharmaceutical drugs market in 2017, pharmaceutical drugs for $X billion or X% market share. North America was the x largest region pharmaceutical drugs for $X billion or X% market share. Western Europe was the x largest region pharmaceutical drugs for $X billion or X% market share.

10. Pharmaceutical Drugs Pharmaceutical Drugs Market Competitive Landscape Competitive Landscape Market The leading competitors in the global pharmaceutical drugs market are Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences Inc. The chart and table below displays the percentage market share of the top players in the pharmaceutical drugs market industry. Novartis AG generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Sanofi S.A. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. F. Hoffmann-La Roche Ltd. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Pfizer Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.

11. Gilead Sciences, Inc. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Johnson & Johnson generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. GlaxosmithKline Plc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Bayer AG generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Teva Pharmaceuticals generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Merck & Co. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year.Company Profile Novartis AG Overview Novartis AG was the largest competitor in the pharmaceutical drugs market in 2017 with a XX% share of the market. Novartis is a multinational pharmaceutical company that develops, manufacture and markets healthcare products. The company was founded in 1970 and is headquartered in Basel, Switzerland. Products and Services The company operates through the following divisions – The Innovative Medicines division focuses on ophthalmology, neuroscience, immunology and The Alcon division focuses on the The Sandoz division focuses on biopharmaceuticals,

12. Strategy Financial Performance Novartis generated revenues of $XX billion for the financial year 2016, a XX% decrease from the previous year. The company had a market Sanofi S.A Overview Products and Services Strategy Financial Performance F. Hoffmann-La Roche Ltd. Overview Products and Services Strategy Financial Performance Pfizer Inc. Overview Products and Services Strategy Financial Performance Gilead Sciences Inc. Overview Products and Services Strategy Financial Performance Novartis’ growth strategy is to focus on strengthening its ophthalmology pipeline through acquisitions. In December 2016, the company acquired pharmaceutical company Encore Vision, Inc. that develops treatment for presbyopia, an ophthalmologic disorder. In addition, Novartis is focusing on licensing new products to